Differential MicroRNA Expression in Osteoporotic and Non-Osteoporotic Trauma Patients: A Potential Biomarker Approach...

Area of Science:

• Biochemistry
• Genetics
• Orthopedics

Background:

• Osteoporosis is a significant global health issue leading to fractures and mortality.
• Dual-energy X-ray absorptiometry (DXA) has limitations in predicting fracture risk.
• MicroRNAs (miRNAs) are implicated in bone metabolism and may serve as osteoporosis biomarkers.

Purpose of the Study:

• Identify differentially expressed miRNAs in osteoporotic vs. non-osteoporotic patients with proximal femur fractures.
• Assess the clinical significance of these miRNAs as diagnostic and prognostic biomarkers for osteoporosis.
• Investigate the role of specific miRNAs in bone metabolism and fracture susceptibility.

Main Methods:

• Prospective case-control study involving 20 patients (10 osteoporotic, 10 non-osteoporotic) with proximal femur fractures.
• Analysis of serum biochemical markers: vitamin D and intact parathyroid hormone (iPTH).
• miRNA profiling using GeneChip® miRNA 4.0 Array, followed by statistical analysis including fold change and FDR correction.

Main Results:

• Osteoporotic patients showed lower vitamin D3 and iPTH levels compared to non-osteoporotic individuals.
• DXA confirmed severe bone loss in osteoporotic patients (T-score: -3.9 to -4.6).
• Significant downregulation of four miRNAs (miR-320b, miR-320c, miR-486-5p, let-7b-5p) was observed in osteoporotic patients.

Conclusions:

• miR-320b, miR-320c, and miR-let-7b are potential biomarkers for osteoporosis and fracture risk.
• Distinct miRNA signatures in osteoporotic fractures may enhance early diagnosis and personalized risk prediction.
• These findings support novel diagnostic and therapeutic strategies for osteoporosis management and fracture prevention.